Search research articles
Contact Us
Filters
Showing results (261-270 of 1,622) with videos related to
Page
of 163
Sort By:
Current Oncology Reports
|
October 3, 2003
Consolidation/maintenance chemotherapy for ovarian cancer
Maurie Markman
Current Oncology Reports
|
December 11, 2003
Is it time for oncologists to modify their laissez-faire attitude toward alternative/complementary 'drug therapy'?
Maurie Markman
The American Journal of Managed Care
|
January 11, 2013
Precision medicine and the rapidly approaching future of cancer management
Maurie Markman
Seminars in Oncology
|
April 1, 1994
Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer
M Markman
Seminars in Oncology
|
August 1, 1994
Introduction: treatment of malignancies poorly responsive to currently available antineoplastic therapy
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Twenty-fifth meeting of the Society of Gynecologic Oncologists. Orlando, Florida, February 1994
M Markman
Cleveland Clinic Journal of Medicine
|
January 1, 1994
Ovarian cancer update: management challenges and advances
M Markman
Gynecologic Oncology
|
October 1, 1993
Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?
M Markman
The Oncologist
|
October 27, 2005
Topotecan as second-line therapy for ovarian cancer: dosage versus toxicity
Maurie Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Report from the 29th annual meeting of the American Society of Clinical Oncology, 16-18 May 1993, Orlando, Florida
M Markman
Page
of 163
Search research articles
Search
Showing results (261-270 of 1,622) with videos related to
Sort By:
Page
of 163
Current Oncology Reports
|
October 3, 2003
Consolidation/maintenance chemotherapy for ovarian cancer
Maurie Markman
Current Oncology Reports
|
December 11, 2003
Is it time for oncologists to modify their laissez-faire attitude toward alternative/complementary 'drug therapy'?
Maurie Markman
The American Journal of Managed Care
|
January 11, 2013
Precision medicine and the rapidly approaching future of cancer management
Maurie Markman
Seminars in Oncology
|
April 1, 1994
Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer
M Markman
Seminars in Oncology
|
August 1, 1994
Introduction: treatment of malignancies poorly responsive to currently available antineoplastic therapy
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Twenty-fifth meeting of the Society of Gynecologic Oncologists. Orlando, Florida, February 1994
M Markman
Cleveland Clinic Journal of Medicine
|
January 1, 1994
Ovarian cancer update: management challenges and advances
M Markman
Gynecologic Oncology
|
October 1, 1993
Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?
M Markman
The Oncologist
|
October 27, 2005
Topotecan as second-line therapy for ovarian cancer: dosage versus toxicity
Maurie Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Report from the 29th annual meeting of the American Society of Clinical Oncology, 16-18 May 1993, Orlando, Florida
M Markman
Page
of 163